Dilip Shanghvi, Chairman of Sun Pharma Advanced Research Company, delivered a speech at the 18th Annual General Meeting discussing the industry landscape and SPARCs response to the shifting external environment in focusing on specific therapeutic categories like cancer and neurodegeneration.